Sangam: A Confluence of Knowledge Streams

Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study.

Show simple item record

dc.creator Strati, P
dc.creator De Vos, S
dc.creator Ruan, J
dc.creator Maddocks, KJ
dc.creator Flowers, CR
dc.creator Rule, S
dc.creator Patel, P
dc.creator Xu, Y
dc.creator Wei, H
dc.creator Frigault, MM
dc.creator Calvo, R
dc.creator Dyer, MJS
dc.date 2022-03-07T14:26:24Z
dc.date 2022-03-07T14:26:24Z
dc.date 2021-10-01
dc.date.accessioned 2022-05-26T21:09:40Z
dc.date.available 2022-05-26T21:09:40Z
dc.identifier http://hdl.handle.net/10026.1/18909
dc.identifier 10.3324/haematol.2021.278654
dc.identifier 1592-8721
dc.identifier.uri http://localhost:8080/xmlui/handle/CUHPOERS/228961
dc.format 2774 - 2778
dc.language eng
dc.language eng
dc.publisher Italy
dc.relation E-ISSN:1592-8721
dc.rights Not known
dc.subject Antineoplastic Combined Chemotherapy Protocols
dc.subject Benzamides
dc.subject Humans
dc.subject Lymphoma, Large B-Cell, Diffuse
dc.subject Pyrazines
dc.title Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study.
dc.type Journal Article


Files in this item

Files Size Format View
10326-Article Text-75841-2-10-20210929.pdf 2.279Mb application/pdf View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse